Taiwan Extracellular Vesicle Medical Promotion Association

Latest News

View More
post_types.news2025/10/17
Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study

##Academic Research #Clinical Laboratory
common.read_more - Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study
post_types.news2025/10/16
2025 Bio-Food Association Members' Conference- Chen Shih-Chung: Three major databases will become the "three arrow" of biotech. Regenerative medicine methods will be complete and drive international expansion.

Taiwan Bioindustry Development Association

##Quality Control
common.read_more - 2025 Bio-Food Association Members' Conference- Chen Shih-Chung: Three major databases will become the "three arrow" of biotech. Regenerative medicine methods will be complete and drive international expansion.

Introduction

Trending Topics

#Medical Technology#Quality Control#Academic Research#International Exchange#Professional Certification#Clinical Laboratory
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
post_types.blogs2025/10/09
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

##Quality Control
common.read_more - Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

About Our Association

Extracellular vesicles represent an emerging biotechnology field in regenerative medicine and precision medicine, demonstrating tremendous potential and limitless applications.

Taiwan possesses deep foundations and advantages in the biomedical technology field. The key lies in establishing comprehensive industry-academia-research-government cooperation mechanisms, setting regulatory standards, enhancing technical capabilities, and improving clinical application quality. Therefore, we established the Taiwan Extracellular Vesicle Medical Promotion Association to unite the forces of industry, academia, and medical communities to jointly promote the development of extracellular vesicle medicine.

Our three core missions: 1. Promote breakthroughs in scientific research and standardization of clinical applications; 2. Create platforms for domestic and international exchange and cooperation; 3. Establish international technical standards and ethical guidelines to enhance international competitiveness.

We believe that through our association's efforts, we can not only improve the quality of extracellular vesicle medicine in Taiwan but also enable Taiwan to occupy a pivotal position in this emerging field. In the future, we hope our association will become a professional organization centered on innovation, quality, and trust, promoting technology translation, accelerating clinical applications, and continuously driving international-level development opportunities.